Herpesvirus vaccines: challenges and future prospects

Area of Science:

• Virology
• Immunology
• Genetics

Background:

• Human herpesviruses are large, double-stranded DNA viruses with complex life cycles.
• These viruses establish lifelong latent infections following initial lytic replication.
• Host immune systems typically control latent infections with minimal impact.

Purpose of the Study:

• To review the life cycle and host-pathogen interactions of human herpesviruses.
• To highlight the potential for severe disease during primary infection, latency, or reactivation.
• To underscore the need for novel vaccine strategies against human herpesviruses.

Main Methods:

• Review of existing literature on human herpesvirus biology and pathogenesis.
• Analysis of host-pathogen co-evolutionary dynamics.
• Examination of clinical outcomes in immunocompromised and immunocompetent individuals.

Main Results:

• Human herpesviruses exhibit a biphasic life cycle: lytic replication followed by lifelong latency.
• Lifelong latency is generally well-controlled by the host immune system, often asymptomatic.
• Severe disease can manifest during primary infection, latency, or reactivation, irrespective of immune status.

Conclusions:

• Human herpesviruses present a significant public health challenge due to their persistence and potential for severe disease.
• Effective vaccine strategies are crucial for preventing initial infection and managing herpesvirus-associated pathologies.
• Further research into host immune control mechanisms and viral pathogenesis is warranted for vaccine development.